BIODESIX INC·4

Nov 13, 4:54 PM ET

Pestano Gary Anthony 4

4 · BIODESIX INC · Filed Nov 13, 2025

Insider Transaction Report

Form 4
Period: 2025-11-10
Pestano Gary Anthony
Chief Development Officer
Transactions
  • Sale

    Common Stock

    2025-11-10$7.62/sh23$1757,939 total
  • Exercise/Conversion

    Common Stock

    2025-11-10+697,962 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-11-106968 total
    Common Stock (69 underlying)
Footnotes (4)
  • [F1]These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.
  • [F2]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
  • [F4]These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

Documents

1 file
  • 4
    form4.xmlPrimary